Our genetic polymorphism analysis study could suggest the possibility that ENPP2 genetic polymorphisms are associated with nociceptive inflammatory pain intensity and opioid dose requirements, although the associations were inconsistent between two types of nociceptive inflammatory pain (i.e., postoperative pain vs. cancer-related pain). Here, ENPP2 is linked to cancer.